Skip to main content
. 2024 Jul 17;24:701. doi: 10.1186/s12879-024-09607-3

Table 1.

Ehrlichiosis Case definitions as established by the Council of State and Territorial Epidemiologists[18]

Confirmed Case Probable Case
Meets clinical evidence and laboratory confirmed criteria Meets clinical evidence and laboratory supportive criteria
Clinical Evidence

One or more of the following:

 ● Fever

 ● Headache

 ● Myalgia

 ● Anemia

 ● Leukopenia

 ● Thrombocytopenia

● Hepatic transaminase elevation

Laboratory Confirmed Laboratory Supportive

Serological evidence of a fourfold change in IgG-specific antibody titer to E. chaffeensis antigen by indirect immunofluorescence assay (IFA) between paired serum samples

OR

Detection of E. chaffeensis DNA in a clinical specimen via amplification of a specific target by polymerase chain reaction (PCR) assay

Serological evidence of elevated IgG or IgM antibody reactive with E. chaffeensis antigen by IFA, enzyme-linked immunosorbent assay (ELISA), dot-ELISA, or assays in other formats*

OR

Identification of morulae in the cytoplasm of monocytes or macrophages by microscopic examination.

*CDC uses an IFA IgG cutoff of > 1:64 and does not use IgM test results independently as diagnostic support criteria.